AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2016

Sep 2, 2016

30583_dirs_2016-09-01_1f0bb3ed-ad17-48f5-be48-d91a6616365e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-07-15

Reporting Person: Dere Willard H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-15	Common Stock	A	2640	—	Acquired	2640	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-15	Stock Option (right to buy Common Stock)	$92.08	A	9880	Acquired	2026-07-14	Common Stock (9880)	Direct

Footnotes

F1: This amendment is being filed solely to correct an administrative error in the original filing regarding the number of stock options and restricted stock units reported as granted.

F2: Restricted stock units granted on July 15, 2016 vest annually over three years. Price not applicable.

F3: Original option grant vests annually over three years